Your browser doesn't support javascript.
loading
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities.
Zhang, Haijun; Lai, Xiaozhen; Patenaude, Bryan N; Jit, Mark; Fang, Hai.
Afiliación
  • Zhang H; Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland
  • Lai X; Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Patenaude BN; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Jit M; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, and Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK; School of Public Health, University of Hong Kong, Hong Kong Special Administrative R
  • Fang H; China Center for Health Development Studies, Peking University, Beijing, China; Peking University Health Science Center-Chinese Center for Disease Control and Prevention Joint Research Center for Vaccine Economics, Peking University, Beijing, China. Electronic address: hfang@hsc.pku.edu.cn.
Lancet Public Health ; 8(12): e1016-e1024, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38000881

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra Rotavirus Límite: Child / Humans / Newborn Idioma: En Revista: Lancet Public Health Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra Rotavirus Límite: Child / Humans / Newborn Idioma: En Revista: Lancet Public Health Año: 2023 Tipo del documento: Article País de afiliación: Suiza